Concepedia

Author

Kristine S. Klos

The University of Texas MD Anderson Cancer Center

Also Known As

K S Klos, Kristine Klos, Kristine S Klos, Kristine S. Klos

23

Publications

3.4K

Citations

14

H-Index

22

Concepts

All Affiliations

The University of Texas MD Anderson Cancer CenterUniversity of Wisconsin–MadisonFudan University Shanghai Cancer Center
KS

About

Kristine S. Klos is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, tumor biology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

2.4K

2

Cell Biology

5

5

517

3

Biomedical Engineering

1

1

72

4

Immunology

1

1

1.8K

5

Pathology

1

1

61

Kristine S. Klos

×

14

Publications

3.4K

Citations

14

H-Index

YearCitations

PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients

Yoichi Nagata, Keng‐Hsueh Lan, Xiaoyan Zhou,

Cancer Cell

2004

1.8K

Activation of the Akt/Mammalian Target of Rapamycin/4E-BP1 Pathway by ErbB2 Overexpression Predicts Tumor Progression in Breast Cancers

Xiaoyan Zhou, Ming Tan, Valerie Stone Hawthorne,

Clinical Cancer Research

2004

312

ErbB2 Increases Vascular Endothelial Growth Factor Protein Synthesis via Activation of Mammalian Target of Rapamycin/p70S6K Leading to Increased Angiogenesis and Spontaneous Metastasis of Human Breast Cancer Cells

Kristine S. Klos, Shannon L. Wyszomierski, Menghong Sun,

Cancer Research

2006

199

Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-β1 in human breast cancer cells

Jun Yao, Shunbin Xiong, Kristine S. Klos,

Oncogene

2001

169

The Wnt Receptor, Lrp5, Is Expressed by Mouse Mammary Stem Cells and Is Required to Maintain the Basal Lineage

Nisha M. Badders, Shruti Goel, Rod J. Clark,

PLoS ONE

2009

129

ErbB2 overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human breast carcinoma

Wentao Yang, Kristine S. Klos, Ying Yang,

Cancer

2002

120

Combined trastuzumab and paclitaxel treatment better inhibits ErbB‐2‐mediated angiogenesis in breast carcinoma through a more effective inhibition of Akt than either treatment alone

Kristine S. Klos, Xiaoyan Zhou, Sangkyou Lee,

Cancer

2003

110

Enhanced sensitization to taxol-induced apoptosis by herceptin pretreatment in ErbB2-overexpressing breast cancer cells.

Sangkyou Lee, Wentao Yang, Keng‐Hsueh Lan,

PubMed

2002

109

ErbB2 Promotes Src Synthesis and Stability: Novel Mechanisms of Src Activation That Confer Breast Cancer Metastasis

Ming Tan, Ping Li, Kristine S. Klos,

Cancer Research

2005

106

Separating Stem Cells by Flow Cytometry: Reducing Variability for Solid Tissues

Caroline M. Alexander, Joel R. Puchalski, Kristine S. Klos,

Cell stem cell

2009

72

Page 1